Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MITO-8: Sequential Chemotherapy in Recurrent Ovarian Cancer
NCT00657878Phase 3Unknown
- Sponsor
- National Cancer Institute
- Start
- Nov 2008
- Primary completion
- Dec 2023
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 3
01
Overview
A Phase 3 trial of pegylated liposomal doxorubicin in ovarian cancer, sponsored by National Cancer Institute. Status: unknown.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00657878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00657878.